Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.27B |
| 2 |
Blackrock
BLK
|
+$1.21B |
| 3 |
PG&E
PCG
|
+$1.17B |
| 4 |
Alibaba
BABA
|
+$1.12B |
| 5 |
T-Mobile US
TMUS
|
+$826M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$1.34B |
| 2 |
Boston Scientific
BSX
|
+$1.26B |
| 3 |
American Express
AXP
|
+$1.23B |
| 4 |
GE Aerospace
GE
|
+$1.1B |
| 5 |
Visa
V
|
+$993M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.88% |
| 2 | Healthcare | 16.37% |
| 3 | Consumer Discretionary | 13.18% |
| 4 | Financials | 11.24% |
| 5 | Communication Services | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
CVR Energy
CVI
$3.13B
| $4.03M | ﹤0.01% |
200,377
-60
| -0% | -$1.21K |
|
2002
Minerals Technologies
MTX
$2.34B
| $4.01M | ﹤0.01% |
85,434
+162
| +0.2% | +$7.09K |
|
2003
Baytex Energy
BTE
$2.92B
| $3.95M | ﹤0.01% |
7,778,414
+271,356
| +4% | +$97.4K |
|
|
JNCE
2004
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $3.89M | ﹤0.01% |
563,974
| – | – |
|
|
AMRN
2005
Amarin Corp
AMRN
$303M
| $3.89M | ﹤0.01% |
28,105
-166
| -0.6% | -$22.8K |
|
2006
Madrigal Pharmaceuticals
MDGL
$11.8B
| $3.88M | ﹤0.01% |
34,241
| – | – |
|
2007
Lakeland Financial Corp
LKFN
$1.53B
| $3.87M | ﹤0.01% |
83,100
-1,735
| -2% | -$71K |
|
2008
Howmet Aerospace
HWM
$112B
| $3.84M | ﹤0.01% |
+242,082
| New | +$3.18M |
|
|
ETRN
2009
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $3.8M | ﹤0.01% |
457,474
+213,229
| +87% | +$1.68M |
|
2010
ACNB Corp
ACNB
$655M
| $3.79M | ﹤0.01% |
144,692
-8,893
| -6% | -$221K |
|
2011
Cars.com
CARS
$660M
| $3.79M | ﹤0.01% |
657,305
+424
| +0.1% | +$2.34K |
|
|
APHA
2012
DELISTED
Aphria Inc. Common Shares
APHA
| $3.78M | ﹤0.01% |
+880,800
| New | +$3.38M |
|
2013
Loews
L
$23.6B
| $3.76M | ﹤0.01% |
109,559
-318,566
| -74% | -$10.7M |
|
2014
Editas Medicine
EDIT
$442M
| $3.75M | ﹤0.01% |
126,833
-29,350
| -19% | -$767K |
|
2015
Goodyear
GT
$1.85B
| $3.74M | ﹤0.01% |
417,740
+95,189
| +30% | +$723K |
|
2016
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.4B
| $3.73M | ﹤0.01% |
113,314
+17,676
| +18% | +$575K |
|
|
FLY
2017
DELISTED
Fly Leasing Limited
FLY
| $3.73M | ﹤0.01% |
453,811
+432,306
| +2,010% | +$3.01M |
|
|
CWBC
2018
Community West Bancshares
CWBC
$684M
| $3.71M | ﹤0.01% |
241,196
+90,104
| +60% | +$1.25M |
|
2019
Choice Hotels
CHH
$4.8B
| $3.7M | ﹤0.01% |
46,950
+12,445
| +36% | +$948K |
|
2020
Lloyds Banking Group
LYG
$91.3B
| $3.68M | ﹤0.01% |
2,454,290
+478,236
| +24% | +$717K |
|
2021
Calix
CALX
$2.39B
| $3.67M | ﹤0.01% |
+246,199
| New | +$2.83M |
|
2022
Kontoor Brands
KTB
$4.26B
| $3.65M | ﹤0.01% |
205,033
+174,836
| +579% | +$3.12M |
|
2023
NETSCOUT
NTCT
$2.79B
| $3.64M | ﹤0.01% |
142,413
+67,788
| +91% | +$1.75M |
|
2024
ReposiTrak
TRAK
$159M
| $3.63M | ﹤0.01% |
858,130
-211,159
| -20% | -$1.02M |
|
2025
Schwab US Large- Cap ETF
SCHX
$74.6B
| $3.62M | ﹤0.01% |
292,782
-9,474
| -3% | -$110K |
|
Similar funds
Fidelity Investments's Q2 2020 Portfolio in Review
As of Q2 2020, Fidelity Investments held 4,490 positions worth $909B, up 26% from $722B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Fidelity Investments's Q2 2020 filing shows 334 new, 1,365 increased, 1,743 reduced and 502 closed positions. Its largest new stake was Royalty Pharma: 16,356,491 shares worth $743M. The largest sale was iShares US Treasury Bond ETF, an estimated $1.34B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fidelity Investments's largest Q2 2020 buy was Royalty Pharma: 16,356,491 shares worth $743M.
- Fidelity Investments added most to Regeneron Pharmaceuticals in Q2 2020, an estimated $2.27B increase.
- Fidelity Investments's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.34B.
- Fidelity Investments fully exited Sprint Corporation in Q2 2020, selling an estimated $225M.
- Fidelity Investments's ten largest holdings make up 28% of its $909B portfolio in Q2 2020.
- Fidelity Investments opened 334 new positions and closed 502 in Q2 2020.
- Fidelity Investments's portfolio value rose 26% quarter-over-quarter to $909B.
Based on Fidelity Investments's 13F filing for Q2 2020, filed 13 Aug 2020.